![Glucocorticoid-induced osteoporosis: mechanisms, management, and future perspectives - The Lancet Diabetes & Endocrinology Glucocorticoid-induced osteoporosis: mechanisms, management, and future perspectives - The Lancet Diabetes & Endocrinology](https://www.thelancet.com/cms/attachment/82caff6c-9a78-425d-bdd6-2e9dd0ecebbd/gr1.jpg)
Glucocorticoid-induced osteoporosis: mechanisms, management, and future perspectives - The Lancet Diabetes & Endocrinology
![Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort study. - Abstract - Europe PMC Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort study. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6817865/bin/41533_2019_150_Fig1_HTML.jpg)
Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort study. - Abstract - Europe PMC
![Vitamin-D status and bone mineral density in asthmatic children on long-term inhaled corticosteroids - Karnataka Paediatric Journal Vitamin-D status and bone mineral density in asthmatic children on long-term inhaled corticosteroids - Karnataka Paediatric Journal](https://iap-kpj.org/content/113/2020/35/1/img/KPJ-35-039-g002.png)
Vitamin-D status and bone mineral density in asthmatic children on long-term inhaled corticosteroids - Karnataka Paediatric Journal
![Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort study. Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort study.](https://sonar.ch/documents/186020/files/fulltext-pdf.jpg)
Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort study.
![Inhaled corticosteroids in children: effects on bone mineral density and growth - The Lancet Respiratory Medicine Inhaled corticosteroids in children: effects on bone mineral density and growth - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/2014639789/2036143653/gr2.jpg)
Inhaled corticosteroids in children: effects on bone mineral density and growth - The Lancet Respiratory Medicine
![Risk of Fracture and Osteoporosis in Patients With COPD and Inhaled Corticosteroids Treatment | Respiratory Care Risk of Fracture and Osteoporosis in Patients With COPD and Inhaled Corticosteroids Treatment | Respiratory Care](https://rc.rcjournal.com/content/respcare/68/12/1719/F4.large.jpg)
Risk of Fracture and Osteoporosis in Patients With COPD and Inhaled Corticosteroids Treatment | Respiratory Care
![Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment | Nature Reviews Endocrinology Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment | Nature Reviews Endocrinology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41574-020-0341-0/MediaObjects/41574_2020_341_Fig1_HTML.png)
Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment | Nature Reviews Endocrinology
![Evaluating the association of osteoporosis with inhaled corticosteroid use in chronic obstructive pulmonary disease in Taiwan | Scientific Reports Evaluating the association of osteoporosis with inhaled corticosteroid use in chronic obstructive pulmonary disease in Taiwan | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-80815-y/MediaObjects/41598_2020_80815_Fig1_HTML.png)
Evaluating the association of osteoporosis with inhaled corticosteroid use in chronic obstructive pulmonary disease in Taiwan | Scientific Reports
![Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort study. - Abstract - Europe PMC Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort study. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6817865/bin/41533_2019_150_Fig3_HTML.jpg)
Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort study. - Abstract - Europe PMC
![Glucocorticoid-induced osteoporosis: mechanisms, management, and future perspectives - The Lancet Diabetes & Endocrinology Glucocorticoid-induced osteoporosis: mechanisms, management, and future perspectives - The Lancet Diabetes & Endocrinology](https://www.thelancet.com/cms/attachment/14ceeb40-d1e4-41f5-90e4-2ace5da25c86/gr3.jpg)
Glucocorticoid-induced osteoporosis: mechanisms, management, and future perspectives - The Lancet Diabetes & Endocrinology
![Frontiers | When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis Frontiers | When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis](https://www.frontiersin.org/files/Articles/782118/fendo-12-782118-HTML-r2/image_m/fendo-12-782118-g001.jpg)